Mucin is one of the major culprits that hinder drug delivery, and several clinical studies identified that mucin is overexpressed in KRAS-driven pancreatic cancer in mouse and human models [140,141,142,143]. The gene discussed is MUC5AC; the disease is familial pancreatic carcinoma.